Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes.

Literature DB >> 17204668

Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes.

Marc Fisher¹, Daniel F Hanley, George Howard, Edward C Jauch, Steven Warach.

Abstract

Entities: Disease

Mesh：

Year: 2007 PMID： 17204668 DOI： 10.1161/01.STR.0000255951.37434.aa

Source DB: PubMed Journal: Stroke ISSN： 0039-2499 Impact factor: 7.914

Keyword Cloud
Cited

× No keyword cloud information.

35 in total

Review 1. Evaluation of combination therapy in animal models of cerebral ischemia.

Authors: Victoria E O'Collins; Malcolm R Macleod; Geoffrey A Donnan; David W Howells
Journal: J Cereb Blood Flow Metab Date: 2012-02-01 Impact factor: 6.200

Review 2. Glutamate receptor ion channels: structure, regulation, and function.

Authors: Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal: Pharmacol Rev Date: 2010-09 Impact factor: 25.468

Review 3. A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury.

Authors: Brian K Kwon; Elena B Okon; Eve Tsai; Michael S Beattie; Jacqueline C Bresnahan; David K Magnuson; Paul J Reier; Dana M McTigue; Phillip G Popovich; Andrew R Blight; Martin Oudega; James D Guest; Lynne C Weaver; Michael G Fehlings; Wolfram Tetzlaff
Journal: J Neurotrauma Date: 2010-10-18 Impact factor: 5.269

4. Neuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration.

Authors: Diana Amantea; Michelangelo Certo; Francesco Petrelli; Giacinto Bagetta
Journal: Assay Drug Dev Technol Date: 2016-07-08 Impact factor: 1.738

5. Aquaporin-4 inhibition mediates piroxicam-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rodents.

Authors: Pallab Bhattacharya; Anand Kumar Pandey; Sudip Paul; Ranjana Patnaik; Dileep R Yavagal
Journal: PLoS One Date: 2013-09-04 Impact factor: 3.240

6. Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones.

Authors: Paul A Lapchak; Jacqueline M Lara; Paul D Boitano
Journal: Transl Stroke Res Date: 2017-04-12 Impact factor: 6.829

Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes.

Review 1. Evaluation of combination therapy in animal models of cerebral ischemia.

Review 2. Glutamate receptor ion channels: structure, regulation, and function.

Review 3. A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury.

4. Neuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration.

5. Aquaporin-4 inhibition mediates piroxicam-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rodents.

6. Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones.

Review 7. Clinical trial design in the neurocritical care unit.

Review 8. Improving the translation of animal ischemic stroke studies to humans.

Review 9. Reversing stroke in the 2010s: lessons from Desmoteplase In Acute ischemic Stroke-2 (DIAS-2).

10. Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems.